Aspirin
- 22 February 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 123 (7), 768-778
- https://doi.org/10.1161/circulationaha.110.963843
Abstract
No abstract availableThis publication has 63 references indexed in Scilit:
- Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trialsThe Lancet, 2010
- Aspirin for the Primary Prevention of Cardiovascular EventsDiabetes Care, 2009
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsThe Lancet, 2009
- Acetylation of prostaglandin H2 synthases by aspirin is inhibited by redox cycling of the peroxidaseBiochemical Pharmacology, 2008
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Aspirin, Heparin, or Both to Treat Acute Unstable AnginaThe New England Journal of Medicine, 1988
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaThe New England Journal of Medicine, 1985
- Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass OperationsThe New England Journal of Medicine, 1984
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaThe New England Journal of Medicine, 1983
- A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened StrokeThe New England Journal of Medicine, 1978